You can help the American Cancer Society fund and support the next revolution in cancer research. When it comes to preventing, detecting and treating cancers – one size doesn’t fit all. The American Cancer Society is funding transformative technology and precision medicine research that can be a game changer in that it can actually do more, is much more accurate, and helps reduce negative side effects.
You can make a difference NOW. Between Oct 5-Oct 14, all funds raised from Relay For Life and Making Strides Against Breast Cancer will be specifically designated to this research revolution with a goal of raising $5,000,000 in these 9 days. Plus all online fundraisers can earn double rewards points to earn some great American Cancer Society swag!
FUNDRAISING LEADERBOARD & PROGRESS TO $5,000,000
Available on Oct 5.
CHECK YOUR EVENT'S RANKING
Available on Oct 5.
EARN 2X REWARDS POINTS
Double the amount of swag you can earn by fundraising from October 5 – October 14. Each dollar you raise online will earn you 2 reward points – find all of the cool stuff you can earn!
*OFFICIAL RULES: All challenge participants who raise funds online between Oct. 5 through 14, 2021 at midnight CST will be eligible to receive double Relay and/or Making Strides Rewards Points for every dollar raised. Only online, credit card, PayPal, and mobile app donations (including checks deposited via the app) qualify; no cash. Double Rewards points will be applied and available for redemption by October 31 (or sooner).
We are on the cusp of amazing advances in cancer research – from work that’s enabling multiple cancers to be detected in a single blood drawn, to discovering new treatments that can target and destroy specific cancer cells with fewer side effects, to improving the ability to determine which personalized treatments will work best for each unique diagnosis. Your participation in the national Fund the Breakthroughs Challenge can help make these advancements a reality, and fuel critical research that is currently underway.
Detect and monitor cancers with a single blood draw.
Alexis Zukowski, PhD
University of Colorado Denver, AMC and DC
Precision Cancer Monitoring
Shannon Stott, PhD
Massachusetts General Hospital
A blood test to understand how glioblastoma responds to treatment
Treatments that target and destroy specific cancer cells with fewer side effects.
Daniel Heller, PhD
Memorial Sloan-Kettering Cancer Center
Guiding drugs to their target with nanoparticles
Jai Patel, PharmD
Personalized Cancer Symptom Management Using Preemptive Pharmacogenomics
Detect which treatments will work best for each individual person with cancer.
Jason Sheltzer, PhD
Using CRISPR to improve targeted therapies
Jennifer Murphy, PhD
Diagnostic tools for monitoring immune responses to cancer immunotherapy
Early detection of cancers that have limited or no options for screening tests right now.
Anne Marie McCarthy, PhD
Univ. of Pennsylvania
A precision medicine approach to breast cancer early detection
Dexing Zeng, PhD
Oregon Health and Science University
Non-invasive imaging to detect lesions before they develop into pancreatic cancer